Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT

PHASE4CompletedINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Asthma
Interventions
OTHER

Telephone follow-up

Asthmatic children being treated, who will be given medical guidance and therapeutic guidance through telephone calls at every fifteen days to the parents or guardians, performed by trained professionals.

OTHER

No telephone follow-up

Asthmatic children being treated, who will be given medical guidance without telephone follow-up calls to parents or guardians.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01476059 - Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT | Biotech Hunter | Biotech Hunter